What type of study is this?

September 30, 2025Open Access

First person – Lucie Perillat

Key Points

Lucie Perillat's work focuses on developing therapeutic models for Becker muscular dystrophy in mice, enhancing understanding of the condition.
Her study includes generating a specific mouse model with a deletion of Dmd exons 52 to 55, which provides insights into genetic disorders.
Perillat emphasizes the importance of ethical frameworks and patient protection in translating research into clinical therapies.
As a PhD student under notable mentorship, her research tackles rare childhood disorders, aiming for efficient clinical application.

Abstract

ABSTRACT First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Lucie Perillat is co-first author on ‘ Generation and characterization of a mouse model of Becker muscular dystrophy with a deletion of Dmd exons 52 to 55’, published in DMM. Lucie is a PhD student in the lab of Dr Ronald Cohn and Dr Evgueni Ivakine at The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada. Her research interests lie in the development of individualized therapies for rare childhood disorders, and the creation of a robust ethical framework to expedite their clinical translation while ensuring the protection of all parties involved – patients and families, scientists, and institutions.

KI fragen

Bookmark

View Full Paper